Bon Natural Life Limited Revenue Growth Rates (BON), Current and Historic Growth - CSIMarket
CSIMarket
 


Bon Natural Life Limited  (NASDAQ: BON)
 

BON's Revenue Growth by Quarter and Year

Bon Natural Life Limited's Revenue results by quarter and year




BON Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 17.88
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 17.88

BONs Annual Revenue
Bon Natural Life Limited's Revenue in the fiscal year 2025 $ 17.88 millions
Bon Natural Life Limited's Revenue in the fiscal year 2024 $ 23.11 millions
Bon Natural Life Limited's Revenue in the fiscal year 2023 $ 28.84 millions
Bon Natural Life Limited's Revenue in the fiscal year 2022 $ 29.91 millions
Bon Natural Life Limited's Revenue in the fiscal year 2021 $ 25.49 millions




BON Revenue fourth quarter 2025 Y/Y Growth Comment
Bon Natural Life Limited reported decline in Revenue in the fourth quarter 2025 by -22.64% to $ 17.88 millions, from the same quarter in 2024.
This represents worst decline in recent Company history.

Looking into fourth quarter 2025 results within Legal Cannabis industry 19 other companies have achieved higher Revenue growth. While Bon Natural Life Limited' s Revenue fall of -22.64% ranks overall at the positon no. 3650 in the fourth quarter 2025.




BON Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter December -22.64 % -19.87 % 13.14 % -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   -22.64 % -19.87 % 13.14 % -

Financial Statements
Bon Natural Life Limited's fourth quarter 2025 Revenue $ 17.88 millions BON's Income Statement
Bon Natural Life Limited's fourth quarter 2024 Revenue $ 23.11 millions Quarterly BON's Income Statement


BON Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   -22.64 % -19.87 % 13.14 % -




Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #20
Consumer Non Cyclical Sector #159
Overall #3650

Revenue Y/Y Growth Statistics
High Average Low
-19.87 % -21.25 % -22.64 %
(Sep 30 2023)   (Sep 30 2024)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #20
Consumer Non Cyclical Sector #159
Overall #3650
Revenue Y/Y Growth Statistics
High Average Low
-19.87 % -21.25 % -22.64 %
(Sep 30 2023)   (Sep 30 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Bon Natural Life Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BON's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BON's IV. Quarter Q/Q Revenue Comment


Bon Natural Life Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2025)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Sep 30 2022)
12 Months Ending
Cumulative Revenue 12 Months Ending $ 17.88 $ 23.11 $ 28.84 $ 29.91 $ 0.00
Y / Y Revenue Growth (TTM) -22.64 % -19.87 % -3.57 % 17.31 % -
Year on Year Revenue Growth Overall Ranking # 963 # 869 # 0 # 1181 # 0
Seqeuential Revenue Change (TTM) -22.64 % -19.87 % -3.57 % 17.31 % -
Seq. Revenue Growth (TTM) Overall Ranking # 963 # 887 # 0 # 1180 # 0


Cumulative Revenue growth Comment
Bon Natural Life Limited's cumulative 12 months Revenue continue to fall, but on the faster rate at -22.64% year on year, at Sep 30 2025 compare to the -19.87% decrease at Sep 30 2024. If the Bon Natural Life Limited's fiscal year would end at Sep 30 2025, annual Revenue would be $18 millions.

Within the Consumer Non Cyclical sector 28 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 869 to 963.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 7
Consumer Non Cyclical Sector # 29
Overall # 963

Revenue TTM Y/Y Growth Statistics
High Average Low
13.12 %
-3.37 %
-19.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 29
S&P 500 # 963
Cumulative Revenue growth Comment
Bon Natural Life Limited's cumulative 12 months Revenue continue to fall, but on the faster rate at -22.64% year on year, at Sep 30 2025 compare to the -19.87% decrease at Sep 30 2024. If the Bon Natural Life Limited's fiscal year would end at Sep 30 2025, annual Revenue would be $18 millions.

Within the Consumer Non Cyclical sector 28 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 869 to 963.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 7
Consumer Non Cyclical Sector # 29
Overall # 963

Revenue TTM Y/Y Growth Statistics
High Average Low
13.12 %
-3.37 %
-19.87 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 7
Sector # 29
S&P 500 # 963




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BON's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Sep 30 2025 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2025
Waldencast Plc-0.63%$ -0.631 millions
Anheuser busch Inbev Sa-0.75%$ -0.750 millions
The Clorox Company-0.77%$ -0.771 millions
Ambev S a -1.35%$ -1.349 millions
Willamette Valley Vineyards Inc -1.51%$ -1.505 millions
Altria Group Inc -1.65%$ -1.655 millions
Farmer Brothers Co-1.75%$ -1.750 millions
Cbdmd Inc -1.89%$ -1.889 millions
Ingredion Incorporated-2.39%$ -2.389 millions
Trulieve Cannabis Corp.-2.66%$ -2.656 millions
Seaboard Corporation-2.90%$ -2.901 millions
Kraft Heinz Co-3.38%$ -3.376 millions
Reed s Inc -3.91%$ -3.912 millions
Zevia Pbc-4.03%$ -4.030 millions
J and j Snack Foods Corp -5.22%$ -5.219 millions
Central Garden and Pet Company-5.96%$ -5.962 millions
Adecoagro S a -6.00%$ -6.003 millions
Cvr Partners Lp-6.08%$ -6.084 millions
Golden Growers Cooperative-6.57%$ -6.572 millions
The Hain Celestial Group Inc -6.81%$ -6.808 millions
Biote Corp -6.87%$ -6.875 millions
Molson Coors Beverage Company-7.44%$ -7.444 millions
Universal Corporation-8.10%$ -8.099 millions
American Vanguard Corporation-8.58%$ -8.583 millions
Mannatech Inc-9.30%$ -9.300 millions
Crimson Wine Group Ltd -10.39%$ -10.386 millions
Ascend Wellness Holdings, Inc.-11.37%$ -11.367 millions
22nd Century Group inc -12.01%$ -12.015 millions
Cibus Inc -12.79%$ -12.789 millions
Archer daniels midland Co-13.68%$ -13.685 millions


About Bon Natural Life Limited Revenue Growth Rates (BON), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bon Natural Life Ltd (CIK 1816815).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-003270
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bon Natural Life Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.